180 related articles for article (PubMed ID: 29998054)
1. Tocilizumab-effective multicentric Castleman's disease with infiltration of eosinophil and IgG
Katsumata Y; Ikari J; Tanaka N; Abe M; Tsushima K; Yonemori Y; Tatsumi K
Respir Med Case Rep; 2018; 25():25-29. PubMed ID: 29998054
[TBL] [Abstract][Full Text] [Related]
2. A Case of Castleman's Disease with a Marked Infiltration of IgG4-Positive Cells in the Renal Interstitium.
Sawada E; Shioda Y; Ogawa K; Iwashita T; Ono Y; Hasegawa H; Maeshima A
Diagnostics (Basel); 2024 Feb; 14(5):. PubMed ID: 38472948
[TBL] [Abstract][Full Text] [Related]
3. A case of immunoglobulin G4-related respiratory disease with multiple lung cysts: A case report.
Mikumo H; Hamada N; Harada E; Yanagihara T; Ogata S; Yabuuchi H; Ijichi K; Takayama K; Nakanishi Y
Respir Med Case Rep; 2017; 21():89-92. PubMed ID: 28443233
[TBL] [Abstract][Full Text] [Related]
4. Multicentric Castleman disease with infiltration of eosinophils to the lung.
Nakai S; Murano M; Hiramatsu T; Matsushima S; Uto T; Sato J; Imokawa S; Suda T
Respir Med Case Rep; 2021; 34():101458. PubMed ID: 34381678
[TBL] [Abstract][Full Text] [Related]
5. Comparison of IgG4-Related Lymphadenopathy and Multicentric Castleman's Disease: a Retrospective Study.
Sun C; Xu G; Lin J
Clin Lab; 2018 Oct; 64(10):1671-1678. PubMed ID: 30336525
[TBL] [Abstract][Full Text] [Related]
6. Diffuse cryptococcal pneumonia in multicentric Castleman's disease with elevated serum IgG
Takiguchi J; Tomioka H; Kamei K; Kawabata Y
BMJ Case Rep; 2023 Mar; 16(3):. PubMed ID: 36944440
[TBL] [Abstract][Full Text] [Related]
7. IL-6 expression helps distinguish Castleman's disease from IgG4-related disease in the lung.
Kinugawa Y; Uehara T; Iwaya M; Asaka S; Kobayashi S; Nakajima T; Komatsu M; Yasuo M; Yamamoto H; Ota H
BMC Pulm Med; 2021 Jul; 21(1):219. PubMed ID: 34246246
[TBL] [Abstract][Full Text] [Related]
8. Comparison of clinical and pathological features of lung lesions of systemic IgG4-related disease and idiopathic multicentric Castleman's disease.
Terasaki Y; Ikushima S; Matsui S; Hebisawa A; Ichimura Y; Izumi S; Ujita M; Arita M; Tomii K; Komase Y; Owan I; Kawamura T; Matsuzawa Y; Murakami M; Ishimoto H; Kimura H; Bando M; Nishimoto N; Kawabata Y; Fukuda Y; Ogura T;
Histopathology; 2017 Jun; 70(7):1114-1124. PubMed ID: 28207938
[TBL] [Abstract][Full Text] [Related]
9. Idiopathic multicentric Castleman's disease: a clinicopathologic study in comparison with IgG4-related disease.
Otani K; Inoue D; Fujikura K; Komori T; Abe-Suzuki S; Tajiri T; Itoh T; Zen Y
Oncotarget; 2018 Jan; 9(6):6691-6706. PubMed ID: 29467920
[TBL] [Abstract][Full Text] [Related]
10. [Multicentric Castleman's disease with multiple hepatic mass lesions mimicking malignant liver tumors].
Ueki T; Nasuno M; Kaiume H; Hiroshima Y; Sumi M; Watanabe M; Inoue D; Masaki Y; Sato Y; Kojima M; Kobayashi H
Rinsho Ketsueki; 2017; 58(6):630-636. PubMed ID: 28679994
[TBL] [Abstract][Full Text] [Related]
11. Cutaneous multicentric Castleman's disease mimicking IgG4-related disease.
Takeuchi M; Sato Y; Takata K; Kobayashi K; Ohno K; Iwaki N; Orita Y; Yoshino T
Pathol Res Pract; 2012 Dec; 208(12):746-9. PubMed ID: 23102767
[TBL] [Abstract][Full Text] [Related]
12. [A case of multicentric Castleman disease with massive infiltration of plasmacytes presenting IgG4].
Ogoshi T; Yatera K; Nagata S; Nishida C; Yamasaki K; Kawanami T; Ishimoto H; Yoshii C; Mukae H
Nihon Kokyuki Gakkai Zasshi; 2011 Jun; 49(6):437-42. PubMed ID: 21735745
[TBL] [Abstract][Full Text] [Related]
13. Distinct features distinguishing IgG4-related disease from multicentric Castleman's disease.
Sasaki T; Akiyama M; Kaneko Y; Mori T; Yasuoka H; Suzuki K; Yamaoka K; Okamoto S; Takeuchi T
RMD Open; 2017; 3(1):e000432. PubMed ID: 28959455
[TBL] [Abstract][Full Text] [Related]
14. Systemic IgG4-related lymphadenopathy: a clinical and pathologic comparison to multicentric Castleman's disease.
Sato Y; Kojima M; Takata K; Morito T; Asaoku H; Takeuchi T; Mizobuchi K; Fujihara M; Kuraoka K; Nakai T; Ichimura K; Tanaka T; Tamura M; Nishikawa Y; Yoshino T
Mod Pathol; 2009 Apr; 22(4):589-99. PubMed ID: 19270642
[TBL] [Abstract][Full Text] [Related]
15. Overlap of IgG4-related Disease and Multicentric Castleman's Disease in a Patient with Skin Lesions.
Mochizuki H; Kato M; Higuchi T; Koyamada R; Arai S; Okada S; Eto H
Intern Med; 2017; 56(9):1095-1099. PubMed ID: 28458319
[TBL] [Abstract][Full Text] [Related]
16. Membranous nephropathy associated with multicentric Castleman's disease that was successfully treated with tocilizumab: a case report and review of the literature.
Saiki R; Katayama K; Hirabayashi Y; Oda K; Fujimoto M; Murata T; Nakajima A; Dohi K
BMC Nephrol; 2021 Jun; 22(1):216. PubMed ID: 34107915
[TBL] [Abstract][Full Text] [Related]
17. Clinical characteristics of a concurrent condition of IgG4-RD and Castleman's disease.
Zhang X; Zhang P; Peng L; Fei Y; Zhang W; Feng R; Zhang W
Clin Rheumatol; 2018 Dec; 37(12):3387-3395. PubMed ID: 29948354
[TBL] [Abstract][Full Text] [Related]
18. [Multicentric Castleman's disease with lymphoid interstitial pneumonia and polyneuropathy].
Mizuno I; Murayama T; Obayashi C; Takahashi K; Miyata Y; Ando M; Sato M; Imoto S; Matsui T; Itoh H; Chihara K
Rinsho Ketsueki; 1998 Aug; 39(8):593-9. PubMed ID: 9785978
[TBL] [Abstract][Full Text] [Related]
19. A case of IgG4-related lung disease associated with multicentric Castleman's disease and lung cancer.
Ikari J; Kojima M; Tomita K; Nakamura T; Toyoda F; Otsuki Y; Shimizu S; Kobayashi H; Nakamura H
Intern Med; 2010; 49(13):1287-91. PubMed ID: 20606361
[TBL] [Abstract][Full Text] [Related]
20. Idiopathic multicentric castleman's disease mimicking immunoglobulin G4-related disease responding well to Bortezomib: a case report.
Peng Q; Wu F; Shi Y; Wang J; Zhai Z; Wang Z
BMC Nephrol; 2023 Oct; 24(1):290. PubMed ID: 37784011
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
